Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Objective
To evaluate the technical and oncological efficacy of an image‐guided cryoablation programme for renal tumours.
Patients and Methods
A prospective analysis of technical and radiological outcomes was undertaken after treatment of 171 consecutive tumours in 147 patients.
Oncological efficacy in a subset of 125 tumours in 104 patients with >6 months' radiological follow‐up and a further subset of 62 patients with solitary, biopsy‐proven renal carcinoma was also analysed.
Factors influencing technical success, as determined by imaging follow‐up, and complication rates were statistically analysed using a statistics software package and logistic regression analyses.
Results
No variables were found to predict subtotal treatment, although gender (P = 0.08), tumour size of >4 cm (P = 0.09) and central location of tumour (P = 0.07) approached significance.
Upper pole location was the single variable that was found to predict complications (P = 0.006).
Among the 104 patients (125 tumours), radiologically assessed at ≥6 months and with a mean radiological follow‐up of 20.1 months, we found a single case of unexpected late local recurrence.
Conclusion
Percutaneous image‐guided cryoablation, at a mean of 20.1 months' follow‐up, appears to provide a safe and effective treatment option with a low complication rate.
Anteriorly sited tumours should not be considered a contraindication for percutaneous image‐guided cryoablation.